Heather Sapp, Phoenix, AZ.
Edwin Kim, MD, Director, University of North Carolina Food Allergy Initiative, Chapel Hill, NC.
Jeff Weiss, MD, allergist, Riverdale, NJ.
Jaclyn Bjelac, Managing Director, Co-Director, Food Allergy Center of Excellence, Cleveland Clinic, Cleveland OH.
Medicine: “Eosinophilic esophagitis as a side effect of food oral immunotherapy.”
Stacy Silvers, Managing Director, Aspire Allergy & Sinus, Austin, TX.
Richard Wasserman, Managing Director, Allergy Partners of North Texas, Dallas.
Sakina Bajowala, Managing Director, Kaneland Allergy and Asthma Center, North Aurora, Ill.
Nikhila Schroeder, MD, allergist, co-founder, Allergenuity Health, Huntersville, NC.
Douglas Mack, MD, allergist, assistant clinical professor of pediatrics, McMaster University, Ontario.
Betsy Grider, Charlotte, NC.
Clinicaltrials.gov: “A Phase 1 Study of the Safety and Feasibility of INT301 Optitration in Peanut Sensitivity Adults.”